search
Ruanyun Edai Technology
Trends
- 1Ruanyun Edai Technology Gets Nasdaq Minimum Bid Price Notice▼Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
Ruanyun Edai Technology Inc., a China-based technology company listed on Nasdaq, has received a deficiency notice after its share price fell below the exchange's $1 minimum bid requirement. Under Nasdaq rules, the company now has a set period, typically 180 days, to bring its stock price back above the threshold, often through a reverse stock split, or face delisting proceedings.
- 2Ruanyun Edai Technology Receives Nasdaq Bid Price Notice●Ruanyun Edai Technology Inc. Receives Nasdaq Notice for Bid Price Non-Compliance
Ruanyun Edai Technology Inc. has received a notice from Nasdaq indicating it is out of compliance with the exchange's minimum bid price requirement for listed securities. Such notices typically give a company a set period, often 180 days, to regain compliance by keeping its share price above the required threshold, or face possible delisting proceedings.
- 3Ruanyun Edai Licenses Cogni AI to BioNexus Gene Lab for Malaysia▼Ruanyun Edai Technology Announces Definitive Agreement to License Cogni AI to BioNexus Gene Lab for Malaysian Healthcare Market
Ruanyun Edai Technology has announced a definitive agreement to license its Cogni AI platform to BioNexus Gene Lab for use in Malaysia's healthcare market. The deal would place the AI technology into Malaysian medical settings through BioNexus Gene Lab's operations. Details on the financial terms and timeline of the agreement have not been disclosed, and reaction to the announcement remains limited so far.